Bone sarcomas are rare, highly malignant mesenchymal tumours that affect teenagers and
young adults, as well as older patients. Despite intensive, multimodal therapy, patients with …

TNF-related apoptosis-inducing ligand (TRAIL) is a prominent cytokine capable of inducing
apoptosis. It can bind to five different cognate receptors, through which diverse intracellular …

Tumor necrosis factor related apoptosis inducing ligand (TRAIL) is a death receptor ligand
that has the ability to preferentially initiate apoptosis in malignant cells with minimal toxicity …

Urinary tract-associated diseases comprise a complex set of disorders with a variety of
etiologic agents and therapeutic approaches and a huge global burden of disease …

The higher frequency of varicocele in men with infertility has drawn attention and resulted in
increased research at the molecular level towards treatments. The aim of this study was to …

The administration of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is one
of the expected cancer therapeutics. However, improvements are required in therapies …

Benign and cancerous prostate tissue is dependent upon androgens. Androgen ablation
causes prostate tissue to undergo apoptosis which thereby provides the rationale of …

肿瘤坏死因子相关的凋亡诱导配体(TRAIL) 是近年来研究发现的肿瘤坏死因子超家族新成员,
其广泛存在于人体组织中, 参与机体免疫调节, 免疫自稳和免疫监视. TRAIL 受体表达于多种细胞 …

Background: TNF-related apoptosis-inducing ligand (TRAIL) can induce cell death in cancer
cells after binding to its TRAIL receptors [TRAILR, Death Receptor 4 (DR4) and Death …

Prostate cancer (PCa) is the most common type of oncological disorder in men, for which an
increasing incidence has been reported. Development and progression of PCa have been …